Condition
Glucagon-Like Peptide-1 Receptor Agonists
Total Trials
5
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
P 1 (2)
P 4 (1)
Trial Status
Not Yet Recruiting3
Enrolling By Invitation2
Clinical Trials (5)
Showing 5 of 5 trials
NCT07319286Phase 1Enrolling By Invitation
Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus
NCT07140289Enrolling By Invitation
Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying
NCT07073053Phase 4Not Yet RecruitingPrimary
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
NCT07014709Not Yet Recruiting
Impact of GLP-1 Receptor Agonists on Patients With IPMN
NCT06520540Phase 1Not Yet RecruitingPrimary
HDM1002 Tablets in Chinese Overweight and Obese Adult Subjects
Showing all 5 trials